Rli Corp (RLI) 68.28 $RLI Atlas Financial (AFH) Q2

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Rli Corp (RLI) 68.28 $RLI

Atlas Financial (AFH) Q2 Earnings Beat on Higher Revenues
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:02AM CDT
Atlas Financial Holdings, Inc. (AFH) reported second-quarter 2016 operating income of 59 cents per share, which comfortably surpassed the Zacks Consensus Estimate of 37 cents. Earnings also increased 18% year over year on higher revenues.
RLI: 68.28 (-0.38), AFH: 16.32 (-0.90), FAF: 40.97 (-0.67), TRV: 117.03 (+0.22)

CNA Financial (CNA) Q2 Earnings Beat Estimates, Surge Y/Y
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 10:28AM CDT
CNA Financial Corporation (CNA) reported second-quarter 2016 operating income of 74 cents per share that beat the Zacks Consensus Estimate of 72 cents by 2.8%.
PGR: 32.55 (+0.05), RLI: 68.28 (-0.38), FAF: 40.97 (-0.67), CNA: 31.50 (+0.49)

Reinsurance Group (RGA) Beats Q2 Earnings, Ups Dividend
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 10:20AM CDT
Reinsurance Group of America Inc. (RGA) reported second-quarter 2016 operating income of $2.80 per share, which beat the Zacks Consensus Estimate of $2.29 by 22.7%.
RLI: 68.28 (-0.38), FAF: 40.97 (-0.67), RGA: 98.77 (+0.70), TRV: 117.03 (+0.22)

Principal Financial (PFG) Q2 Earnings Beat, Increase Y/Y
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 10:15AM CDT
Principal Financial Group Inc. (PFG) reported second-quarter 2016 operating net income of $1.15 per share that surpassed the Zacks Consensus Estimate of $1.06 by 8.5%.
PGR: 32.55 (+0.05), RLI: 68.28 (-0.38), PFG: 45.28 (-0.95), NDAQ: 71.20 (-0.22)

Aflac (AFL) Q2 Earnings Beat, Revenues Miss; View Retained
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 10:12AM CDT
Aflac Incorporated's (AFL) second-quarter 2016 operating earnings per share of $1.71 beat the Zacks Consensus Estimate of $1.68 by about 1.8%.
PGR: 32.55 (+0.05), BRO: 36.49 (-0.13), RLI: 68.28 (-0.38), AFL: 71.62 (+0.04)

The HartFord (HIG) Q2 Earnings Miss Estimates, Plunge Y/Y
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 9:46AM CDT
The Hartford Financial Services Group, Inc. (HIG) reported second-quarter 2016 operating earnings of 31 cents per share
PGR: 32.55 (+0.05), RLI: 68.28 (-0.38), FAF: 40.97 (-0.67), HIG: 40.12 (+0.11)

Amerisafe (AMSF) Earnings, Revenues Miss Estimates in Q2
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 9:43AM CDT
Amerisafe Inc.'s (AMSF) second-quarter 2016 operating earnings per share of 85 cents missed the Zacks Consensus Estimate by 1.2%. Nonetheless, the bottom line inched up 1.2% year over year.
AMSF: 55.86 (+0.30), RLI: 68.28 (-0.38), FAF: 40.97 (-0.67), TRV: 117.03 (+0.22)

CME Group (CME) Q2 Earnings Beat Estimates, Increase Y/Y
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 10:02AM CDT
CME Group Inc. (CME) reported second-quarter 2016 adjusted earnings per share of a record $1.14, which surpassed the Zacks Consensus Estimate of $1.11 by 2.7%.
PGR: 32.55 (+0.05), CME: 103.29 (+0.20), RLI: 68.28 (-0.38), NDAQ: 71.20 (-0.22)

Marsh & McLennan (MMC) Reports In Line Earnings in Q2
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 9:36AM CDT
Marsh & McLennan's (MMC) second-quarter 2016 operating earnings per share of 91 cents, in line with the Zacks Consensus Estimate. Earnings improved 13.8% year over year.
RLI: 68.28 (-0.38), FAF: 40.97 (-0.67), TRV: 117.03 (+0.22), MMC: 66.09 (+0.15)

Torchmark (TMK) Q2 Earnings and Revenues Beat Estimates
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 9:21AM CDT
Torchmark Corporation's (TMK) second-quarter 2016 net operating income of $1.11 per share beat the Zacks Consensus Estimate by a penny.
TMK: 60.95 (-0.34), RLI: 68.28 (-0.38), FAF: 40.97 (-0.67), TRV: 117.03 (+0.22)

XL Group (XL) Beats on Q2 Earnings and Revenue Estimates
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 9:19AM CDT
XL Group plc (XL) reported second-quarter 2016 operating net income of 37 cents per share that comfortably surpassed the Zacks Consensus Estimate by 60.9%.
PGR: 32.55 (+0.05), RLI: 68.28 (-0.38), FAF: 40.97 (-0.67), XL: 33.80 (-0.28)

Unum Group (UNM) Beats on Q2 Earnings, Revises Guidance
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 8:22AM CDT
Unum's (UNM) operating net income of 99 cents per share in the second quarter of 2016 beat the Zacks Consensus Estimate by 5 cents. The bottom line improved by a dime year over year.
RLI: 68.28 (-0.38), FAF: 40.97 (-0.67), UNM: 32.86 (-0.15), TRV: 117.03 (+0.22)

AXIS Capital (AXS) Q2 Earnings Beat, Fall Y/Y on Cat Loss
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 10:12AM CDT
AXIS Capital (AXS) reported second-quarter 2016 earnings per share of 51 cents beat the beating the Zacks Consensus Estimate by 45%. However, earnings plunged 45.2% year over year.
AXS: 55.25 (-0.14), RLI: 68.28 (-0.38), FAF: 40.97 (-0.67), TRV: 117.03 (+0.22)

Nasdaq (NDAQ) Beats on Earnings in Q2: Will Stock Gain?
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 10:07AM CDT
Nasdaq (NDAQ) posted second-quarter 2016 earnings of 91 cents per share, which beat the Zacks Consensus Estimate by 3.4%. The bottom line also improved 9.6% from 83 cents earned in the prior-year quarter.
RLI: 68.28 (-0.38), FAF: 40.97 (-0.67), NDAQ: 71.20 (-0.22), TRV: 117.03 (+0.22)

RenaissanceRe (RNR) Q2 Earnings Miss on Higher Expenses
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 9:48AM CDT
RenaissanceRe Holdings Ltd.'s (RNR) second-quarter 2016 operating earnings per share of $1.55 missed the Zacks Consensus Estimate of $2.01 by 22.9%.
PGR: 32.55 (+0.05), RLI: 68.28 (-0.38), RNR: 116.83 (-0.14), FAF: 40.97 (-0.67)

Chubb Limited (CB) Q2 Earnings Miss Estimates, Decline Y/Y
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 9:41AM CDT
Chubb Limited (CB) reported second-quarter 2016 operating income of $2.25 per share, which missed the Zacks Consensus Estimate of $2.26 by 0.4%.
PGR: 32.55 (+0.05), RLI: 68.28 (-0.38), FAF: 40.97 (-0.67), CB: 125.03 (-0.24)

CNO Financial (CNO) Q2 Earnings & Revenues Beat; Up Y/Y
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 9:34AM CDT
CNO Financial Group, Inc.'s (CNO) second-quarter 2016 net operating earnings of 35 cents per share beat the Zacks Consensus Estimate of 34 cents by 2.9%.
PGR: 32.55 (+0.05), RLI: 68.28 (-0.38), FAF: 40.97 (-0.67), CNO: 15.30 (-0.67)

Assurant's (AIZ) Q2 Earnings Top, Revenues Lag Estimates
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 9:16AM CDT
Assurant, Inc. (AIZ) reported second-quarter 2016 net operating income of $1.42 per share that beat the Zacks Consensus Estimate by 0.7%.
PGR: 32.55 (+0.05), BRO: 36.49 (-0.13), RLI: 68.28 (-0.38), AIZ: 83.29 (+0.04)

Cincinnati Financial (CINF) Q2 Earnings Beat, Revenues Up
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 9:13AM CDT
Cincinnati Financial Corp. (CINF) reported second-quarter 2016 operating income of 57 cents per share, which comfortably surpassed the Zacks Consensus Estimate of 52 cents by 9.6%.
PGR: 32.55 (+0.05), CINF: 74.89 (-0.19), RLI: 68.28 (-0.38), FAF: 40.97 (-0.67)

W.R. Berkley Corp (WRB) Q2 Earnings Beat, Increase Y/Y
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 9:29AM CDT
W.R. Berkley Corp. (WRB) reported second-quarter 2016 operating income of 82 cents per share that beat the Zacks Consensus Estimate by 3.8%.
RLI: 68.28 (-0.38), FAF: 40.97 (-0.67), WRB: 58.13 (unch), TRV: 117.03 (+0.22)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Build-A-Bear Lawsuit Notice Carries a Date Problem

Updated Category News Views 26

Something is badly out of sequence in the Build-A-Bear shareholder alert, and that matters before anybody gets carried away by the legal boilerplate. The notice says investors who bought NYSE: BBW securities from March 28, 2026 through August 26, 2026 may be covered by a proposed federal securities class action. It also says the lead-plaintiff deadline is January 19,...

Continue Reading

Top 5 Most Recently Viewed Articles

NuCana Discontinues Phase 2 Colorectal Cancer Study

Updated Category News Views 146

NuCana Provides Update on Phase 2 Randomized Colorectal Cancer Study NuTide:323 Study Discontinued Following Initial Analysis Ongoing Studies Show Promise with NUC-7738 and Pembrolizumab NuCana plc (NASDAQ: NCNA) has shared important updates about its clinical trials focused on innovative treatments for colorectal cancer. The company has made the decision to discontinue...

Continue Reading
Brøndbyernes IF Football Meeting - Key Highlights Recap

Updated Category News Views 179

Overview of the Annual General Meeting for Brøndbyernes IF Football A/S BRØNDBYERNES I.F. FODBOLD A/S CVR-nr. 83 93 34 10 This report summarizes the outcomes of the annual general meeting conducted by Brøndbyernes IF Football A/S. Key Date and Location The annual shareholders meeting took place, gathering stakeholders and shareholders at the club's headquarters. A...

Continue Reading
Uncovering the Wealth from Investing in BlackRock

Updated Category News Views 314

The Potential Growth of $1000 in BlackRock Investors often wonder how their money would grow over time if invested in strong companies. Recently, we looked into BlackRock, Inc., known by its stock ticker BLK. Over a span of 15 years, investing just $1000 into BlackRock stocks would yield an impressive value today. According to current evaluations, if you had made that...

Continue Reading
Zealand Pharma Advances Glepaglutide Approval for SBS Treatment

Updated Category News Views 267

Glepaglutide Submission to EMA Marks Significant Progress Zealand Pharma A/S, a pioneering biotechnology company, has recently shared exciting news about its Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for its innovative drug, glepaglutide. This long-acting GLP-2 analog is specifically designed for treating adults suffering from short...

Continue Reading
Seven Gables Real Estate Partners with Local Logic for Insights

Updated Category News Views 40

Seven Gables Real Estate Partners with Local Logic In a significant move that underscores their dedication to innovation, Seven Gables Real Estate has announced an exciting partnership with Local Logic, a leader in location intelligence. This collaboration is set to incorporate Local Logic's cutting-edge products—Local Content, Local Search, and NeighborhoodWrap—into...

Continue Reading